Clinical trial
Randomized Multicenter Clinical Trial in Heart Failure Patients With Preserved Ejection Fraction (HFpEF) at Intermediate and High Risk of All-cause Death
NCT06532019 is registered in ClinicalTrials.gov with Xiangtan Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Multicenter Clinical Trial in Heart Failure Patients With Preserved Ejection Fraction (HFpEF) at Intermediate and High Risk of All-cause Death
- Lead sponsor
- Xiangtan Central Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 1, 2024
- Completion date
- August 1, 2028
- Enrollment
- 924 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure with preserved ejection fraction